Intra-Tumor AvidinOX Allows Efficacy of Low Dose Systemic Biotinylated Cetuximab in a Model of Head and Neck Cancer
Oncotarget - United States
doi 10.18632/oncotarget.6089
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 9, 2015
Authors
Publisher
Impact Journals, LLC